DÖLARSLAN M. CRISPR-Cas9 Mediated Gene Correction of CFTR Mutations in Cystic Fibrosis: Evaluating Efficacy, Safety, and Long-Term Outcomes in Patient-Derived Lung Organoids. SHIFAA [Internet]. 2023 May 19 [cited 2025 Aug. 1];2023:41-7. Available from: https://peninsula-press.ae/Journals/index.php/SHIFAA/article/view/5